Hikma Pharmaceuticals (HKMPY)

PNK: HKMPY · Real-Time Price · USD

53.81

0.84 (1.59%)

At close: May 02, 2025, 3:45 PM

Hikma Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	188M	236M	205M	272M	270M	371M	426M	322M	323M	413M	442M	322M	276M	220M	227M	244M	155M	247M
Short-Term Investments	25M	24M	103M	22M	22M	22M	24M	24M	24M	23M	23M	22M	21M	21M	22M	21M	20M	21M
Long-Term Investments	51M	63M	10M	29M	53M	30M	33M	26M	24M	15M	6M	8M	17M	8M	6M	54M	-6M	46M
Other Long-Term Assets	44M	268M	103M	43M	22M	39M	24M	24M	24M	23M	37M	52M	51M	60M	60M	21M	61M	21M
Receivables	905M	937M	789M	846M	777M	784M	781M	693M	662M	560M	637M	610M	654M	604M	650M	635M	751M	590M
Inventory	986M	936M	891M	859M	776M	765M	695M	736M	757M	684M	568M	579M	528M	534M	488M	507M	459M	496M
Other Current Assets	86M	71M	119M	92M	80M	122M	103M	102M	100M	132M	129M	114M	132M	105M	146M	63M	71M	145M
Total Current Assets	2.26B	2.29B	2.1B	2.18B	2B	2.14B	2.09B	1.96B	1.92B	1.88B	1.85B	1.7B	1.67B	1.54B	1.57B	1.47B	1.45B	1.57B
Property-Plant & Equipment	1.33B	1.14B	1.14B	1.09B	1.08B	1.13B	1.15B	1.06B	1.07B	970M	962M	912M	870M	841M	828M	982M	969M	982M
Goodwill & Intangibles	1.16B	1.09B	1.1B	1.08B	1.12B	1.25B	892M	906M	876M	850M	834M	801M	766M	776M	785M	1.69B	1.72B	1.76B
Total Long-Term Assets	2.87B	2.56B	2.58B	2.44B	2.47B	2.6B	2.28B	2.23B	2.21B	2.09B	2.08B	1.91B	1.83B	1.8B	1.81B	2.93B	2.92B	2.94B
Total Assets	5.13B	4.85B	4.68B	4.62B	4.47B	4.75B	4.37B	4.18B	4.13B	3.97B	3.93B	3.61B	3.5B	3.35B	3.39B	4.39B	4.36B	4.5B
Account Payables	358M	541M	309M	505M	291M	255M	262M	226M	279M	272M	286M	248M	263M	219M	218M	191M	172M	180M
Deferred Revenue	n/a	n/a	226M	295M	193M	199M	294M	134M	146M	68M	105M	402M	444M	405M	382M	389M	432M	381M
Short-Term Debt	642M	206M	150M	211M	139M	128M	112M	172M	158M	129M	569M	588M	74M	89M	86M	111M	117M	158M
Other Current Liabilities	863M	486M	-31M	130M	173M	143M	115M	125M	70M	256M	378M	331M	397M	286M	261M	307M	377M	366M
Total Current Liabilities	1.98B	1.38B	1.34B	1.22B	1.08B	1.01B	1.02B	960M	1.03B	1.07B	1.47B	1.32B	893M	814M	797M	772M	918M	866M
Long-Term Debt	607M	1.02B	975M	1.03B	1.07B	1.34B	651M	676M	692M	730M	48M	40M	539M	608M	670M	747M	721M	892M
Other Long-Term Liabilities	133M	80M	70M	85M	92M	108M	140M	145M	164M	189M	203M	318M	329M	332M	324M	384M	277M	324M
Total Long-Term Liabilities	834M	1.17B	1.13B	1.2B	1.25B	1.55B	889M	917M	959M	1B	330M	438M	907M	990M	1.06B	1.17B	1.03B	1.24B
Total Liabilities	2.81B	2.55B	2.47B	2.42B	2.32B	2.56B	1.91B	1.88B	1.99B	2.07B	1.8B	1.76B	1.8B	1.8B	1.86B	1.94B	1.95B	2.1B
Total Debt	1.31B	1.28B	1.19B	1.31B	1.28B	1.55B	846M	932M	932M	927M	685M	695M	637M	721M	777M	880M	860M	1.07B
Common Stock	40M	40M	40M	40M	40M	41M	42M	41M	41M	41M	41M	40M	40M	40M	40M	40M	40M	40M
Retained Earnings	2.36B	2.29B	2.16B	2.15B	2.09B	2.11B	2.19B	2.03B	1.89B	1.72B	1.97B	1.72B	1.58B	1.42B	1.38B	2.12B	1.25B	1.16B
Comprehensive Income	n/a	-323M	-282M	-279M	-279M	-254M	-60M	-65M	-80M	-156M	-178M	-204M	-216M	-209M	-189M	848M	829M	901M
Shareholders Equity	2.31B	2.29B	2.2B	2.19B	2.13B	2.18B	2.45B	2.29B	2.13B	1.89B	2.12B	1.83B	1.69B	1.53B	1.51B	2.44B	2.4B	2.38B
Total Investments	76M	87M	113M	51M	75M	52M	57M	36M	48M	32M	43M	30M	38M	29M	22M	75M	14M	67M